Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Non-Current Deferred Tax Liability (2016 - 2025)

China Pharma Holdings filings provide 16 years of Non-Current Deferred Tax Liability readings, the most recent being $747805.0 for Q4 2025.

  • On a quarterly basis, Non-Current Deferred Tax Liability rose 2.27% to $747805.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $747805.0, a 2.27% increase, with the full-year FY2025 number at $747805.0, up 2.27% from a year prior.
  • Non-Current Deferred Tax Liability hit $747805.0 in Q4 2025 for China Pharma Holdings, up from $739733.0 in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $827978.0 in Q1 2022 to a low of $727417.0 in Q2 2023.
  • Median Non-Current Deferred Tax Liability over the past 5 years was $744959.5 (2023), compared with a mean of $761736.2.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: increased 9.59% in 2021 and later decreased 8.65% in 2022.
  • China Pharma Holdings' Non-Current Deferred Tax Liability stood at $824407.0 in 2021, then decreased by 8.46% to $754698.0 in 2022, then dropped by 1.67% to $742114.0 in 2023, then decreased by 1.47% to $731202.0 in 2024, then rose by 2.27% to $747805.0 in 2025.
  • The last three reported values for Non-Current Deferred Tax Liability were $747805.0 (Q4 2025), $739733.0 (Q3 2025), and $734246.0 (Q2 2025) per Business Quant data.